These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2105595)

  • 1. Malignant hyperphenylalaninemia: CT and MR of the brain.
    Brismar J; Aqeel A; Gascon G; Ozand P
    AJNR Am J Neuroradiol; 1990; 11(1):135-8. PubMed ID: 2105595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain CT and MR findings in hyperphenylalaninemia due to dihydropteridine reductase deficiency (variant of phenylketonuria).
    Sugita R; Takahashi S; Ishii K; Matsumoto K; Ishibashi T; Sakamoto K; Narisawa K
    J Comput Assist Tomogr; 1990; 14(5):699-703. PubMed ID: 2398144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cranial CT and MRI in malignant phenylketonuria.
    Gudinchet F; Maeder P; Meuli RA; Deonna T; Mathieu JM
    Pediatr Radiol; 1992; 22(3):223-4. PubMed ID: 1508595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels.
    Pardo J; Capdevila-Lacasa C; Segura B; Pané A; Montserrat C; de Talló Forga-Visa M; Moreno PJ; Garrabou G; Grau-Junyent JM; Junqué C;
    J Neurodev Disord; 2024 Jun; 16(1):33. PubMed ID: 38907189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia.
    Bartholomé K; Lutz P; Bickel H
    Pediatr Res; 1975 Dec; 9(12):899-903. PubMed ID: 1196708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria.
    Christ SE; Price MH; Bodner KE; Saville C; Moffitt AJ; Peck D
    Mol Genet Metab; 2016 May; 118(1):3-8. PubMed ID: 26947918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No white matter abnormalities in untreated patients with persistent hyperphenylalaninaemia: findings in magnetic resonance imaging. German PKU Collaborative Study.
    Weglage J; Ullrich K; Schuierer G; Pietsch M; Fünders B
    Eur J Pediatr; 1994 Dec; 153(12):918-9. PubMed ID: 7859796
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
    Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
    Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cranial MR in phenylketonuria.
    Shaw DW; Weinberger E; Maravilla KR
    J Comput Assist Tomogr; 1990; 14(3):458-60. PubMed ID: 2335616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter pathology in phenylketonuria.
    Anderson PJ; Leuzzi V
    Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Hypotyrosinemia" in phenylketonuria.
    Hanley WB; Lee AW; Hanley AJ; Lehotay DC; Austin VJ; Schoonheyt WE; Platt BA; Clarke JT
    Mol Genet Metab; 2000 Apr; 69(4):286-94. PubMed ID: 10870846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia.
    Butler IJ; O'Flynn ME; Seifert WE; Howell RR
    J Pediatr; 1981 May; 98(5):729-33. PubMed ID: 6112253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.
    Fiege B; Blau N
    J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).
    Winn SR; Scherer T; Thöny B; Harding CO
    Mol Genet Metab; 2016 Jan; 117(1):5-11. PubMed ID: 26653793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.